000			01695 a2200481 4500
005			20250511202438.0
264		0	_c19920303
008			199203s 0 0 eng d
022			_a0013-7227
024	7		_a10.1210/endo.130.2.1733721 _2doi
040			_aNLM _beng _cNLM
100	1		_aHofmann, C A
245	0	0	_aTreatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. _h[electronic resource]
260			_bEndocrinology _cFeb 1992
300			_a735-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aCrosses, Genetic
650	0	4	_aDiabetes Mellitus _xgenetics
650	0	4	_aDiabetes Mellitus, Experimental _xgenetics
650	0	4	_aFemale
650	0	4	_aHypoglycemic Agents _xpharmacology
650	0	4	_aInsulin _xblood
650	0	4	_aInsulin Resistance
650	0	4	_aKinetics
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Obese
650	0	4	_aMonosaccharide Transport Proteins _xgenetics
650	0	4	_aObesity
650	0	4	_aPhosphoenolpyruvate Carboxykinase (GTP) _xgenetics
650	0	4	_aPioglitazone
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aThiazoles _xpharmacology
650	0	4	_aThiazolidinediones
700	1		_aEdwards, C W
700	1		_aHillman, R M
700	1		_aColca, J R
773	0		_tEndocrinology _gvol. 130 _gno. 2 _gp. 735-40
856	4	0	_uhttps://doi.org/10.1210/endo.130.2.1733721 _zAvailable from publisher's website
999			_c1740118 _d1740118